Breaking down the data according to cancer type, it becomes clear that melanoma has the highest proportion of potentially actionable mutations (mostly BRAF), followed by pancreatic cancer (KRAS) and colorectal cancer (KRAS and PIK3CA) as seen in Figure 5. The gene discussed is BRAF; the disease is pancreatic neoplasm.